Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fonc.2020.01578 http://scihub22266oqcxt.onion/10.3389/fonc.2020.01578 32984017!7493633!32984017     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32984017&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Front+Oncol 2020 ; 10 (?): 1578 Nephropedia Template TP {{tp|p=32984017|t=2020. Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab |pdf=|usr=}}{{32984017}} gab.com Text Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab JO: Front Oncol http://www.kidney.de/pget.php?&tw=1&pmid=32984017 #FOAvip Patients with pre-existing comorbidities and immunosuppression are at greater risk for SARS-CoV-2 infection and severe manifestations of COVID-19. This also includes cancer patients, who are shown to have a poor prognosis after infection. Here, we describe the case of a 72-year old male patient with B-cell depletion after maintenance treatment with rituximab for non-Hodgkin-lymphoma who had a prolonged COVID-19 course and initial false negative test results. Our case highlights the diagnostic pitfalls in diagnosing COVID-19 in B-cell depleted patients and discuss the role of B-cell depletion in the course and treatment of COVID-19. Furthermore, we investigated peripheral blood monocytes and SARS-CoV-2 specific T cells in our patient. In conclusion, our case report can help physicians to avoid diagnostic pitfalls for COVID-19 in hemato-oncological patients under chemoimmunotherapy and tries to explain the role of B-cell depletion and SARS-CoV-2 specific T cells in this context. Twit Text FOAVip Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab ????Front Oncol http://www.kidney.de/pget.php?&tw=1&pmid=32984017 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32984017 #FOAvip English Wikipedia <ref>{{Cite pmid|32984017}}</ref> Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab #MMPMID32984017 Kos I; Balensiefer B; Roth S; Ahlgrimm M; Sester M; Schmidt T; Thurner L; Bewarder M; Bals R; Lammert F; Stilgenbauer S; Kaddu-Mulindwa D Front Oncol 2020[]; 10 (?): 1578 PMID32984017show ga Patients with pre-existing comorbidities and immunosuppression are at greater risk for SARS-CoV-2 infection and severe manifestations of COVID-19. This also includes cancer patients, who are shown to have a poor prognosis after infection. Here, we describe the case of a 72-year old male patient with B-cell depletion after maintenance treatment with rituximab for non-Hodgkin-lymphoma who had a prolonged COVID-19 course and initial false negative test results. Our case highlights the diagnostic pitfalls in diagnosing COVID-19 in B-cell depleted patients and discuss the role of B-cell depletion in the course and treatment of COVID-19. Furthermore, we investigated peripheral blood monocytes and SARS-CoV-2 specific T cells in our patient. In conclusion, our case report can help physicians to avoid diagnostic pitfalls for COVID-19 in hemato-oncological patients under chemoimmunotherapy and tries to explain the role of B-cell depletion and SARS-CoV-2 specific T cells in this context. ?Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted(epmc).pdf DeepDyve Pubget Overpricing